DJ Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slid 2.12% to $58.11 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.27% to 6,606.49 and Dow Jones Industrial Average falling 0.44% to 46,021.43.
This was the stock's second consecutive day of losses.
Bristol Myers Squibb Co. closed 7.60% short of its 52-week high of $62.89, which the company achieved on March 2nd.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.13% to $237.60, Pfizer Inc. $(PFE)$ rose 0.33% to $27.41, and Abbott Laboratories $(ABT)$ fell 1.20% to $107.19.
Trading volume (12.4 M) remained 552,353 below its 50-day average volume of 13.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 19, 2026 16:38 ET (20:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
